4′-fluoro nucleosides for the treatment of HCV
US-9211300-B2 · Dec 15, 2015 · US
US9045520B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9045520-B2 |
| Application number | US-201213491437-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 7, 2012 |
| Priority date | Dec 23, 2008 |
| Publication date | Jun 2, 2015 |
| Grant date | Jun 2, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula IV: or a salt thereof, wherein: R 5 is H or N 3 ; R 6 is CH 3 ; R 11 is a protecting group; and X is F. 2. A compound of formula V: or a salt thereof, wherein: R 5 is N 3 ; R…
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Cross-Sectional Technologies · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.